Last updated: 16 June 2019 at 7:20pm EST

Lawrence Baldini Net Worth




The estimated Net Worth of Lawrence Baldini is at least 3.05 百万$ dollars as of 12 November 2018. Lawrence Baldini owns over 35,101 units of Meridian Bioscience stock worth over 2,250,614$ and over the last 21 years Lawrence sold VIVO stock worth over 800,815$.

Lawrence Baldini VIVO stock SEC Form 4 insiders trading

Lawrence has made over 7 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently Lawrence sold 35,101 units of VIVO stock worth 681,310$ on 12 November 2018.

The largest trade Lawrence's ever made was selling 35,101 units of Meridian Bioscience stock on 12 November 2018 worth over 681,310$. On average, Lawrence trades about 2,832 units every 57 days since 2003. As of 12 November 2018 Lawrence still owns at least 66,253 units of Meridian Bioscience stock.

You can see the complete history of Lawrence Baldini stock trades at the bottom of the page.



What's Lawrence Baldini's mailing address?

Lawrence's mailing address filed with the SEC is 3471 RIVER HILLS DRIVE, , CINCINNATI, OH, 45244.

Insiders trading at Meridian Bioscience

Over the last 22 years, insiders at Meridian Bioscience have traded over 8,089,514$ worth of Meridian Bioscience stock and bought 228,244 units worth 3,053,655$ . The most active insiders traders include Richard EberlyJohn P. KennyJohn A Kraeutler. On average, Meridian Bioscience executives and independent directors trade stock every 41 days with the average trade being worth of 424,761$. The most recent stock trade was executed by James M. Anderson on 6 January 2023, trading 8,500 units of VIVO stock currently worth 173,230$.



What does Meridian Bioscience do?

Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.



What does Meridian Bioscience's logo look like?

Meridian Bioscience Inc. logo

Complete history of Lawrence Baldini stock trades at Meridian Bioscience

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
12 Nov 2018 Lawrence Baldini
副総裁、オペレーション
販売 35,101 19.41$ 681,310$
12 Nov 2018
66,253
26 Jan 2017 Lawrence Baldini
副総裁、オペレーション
購入する 4,000 12.70$ 50,800$
26 Jan 2017
106,934
3 Nov 2016 Lawrence Baldini
副総裁、オペレーション
購入する 4,900 16.00$ 78,400$
3 Nov 2016
95,501
19 Nov 2013 Lawrence Baldini
副総裁、オペレーション
販売 4,926 24.26$ 119,505$
19 Nov 2013
75,500
26 Jul 2013 Lawrence Baldini
副総裁、オペレーション
オプション行使 32,000 24.25$ 776,000$
26 Jul 2013
102,000
3 Dec 2012 Lawrence Baldini
副総裁、オペレーション
購入する 32,500 20.07$ 652,275$
3 Dec 2012
70,000
6 May 2011 Lawrence Baldini
副総裁、オペレーション
オプション行使 22,500 2.09$ 47,025$
6 May 2011
55,000


Meridian Bioscience executives and stock owners

Meridian Bioscience executives and other stock owners filed with the SEC include: